相似文献
1
Acute respiratory disease in normal volunteers associated with Coxsackie A-21 viral infection. III. Response to nasopharyngeal and enteric inoculation.
J Clin Invest. 1963 Jun;42(6):840-52. doi: 10.1172/JCI104776.
2
Factors influencing response of volunteers to inoculation with Coxsackie virus A type 21.
Am Rev Respir Dis. 1969 Jan;99(1):24-30. doi: 10.1164/arrd.1969.99.1.24.
3
RESPONSE OF VOLUNTEERS TO INOCULATION WITH HEMAGGLUTININ-POSITIVE AND HEMAGGLUTININ-NEGATIVE VARIANTS OF COXSACKIE A21 VIRUS.
J Clin Invest. 1965 Jul;44(7):1125-31. doi: 10.1172/JCI105219.
4
THE SPECIFICITY OF THE ANTIBODY RESPONSES OF HUMAN VOLUNTEERS TO CERTAIN RESPIRATORY VIRUSES.
J Hyg (Lond). 1964 Mar;62(1):115-9. doi: 10.1017/s0022172400039814.
5
Saffold cardiovirus infection in children associated with respiratory disease and its similarity to coxsackievirus infection.
Pediatr Infect Dis J. 2011 Aug;30(8):680-3. doi: 10.1097/INF.0b013e31821608a8.
6
STUDIES IN VOLUNTEERS WITH RESPIRATORY VIRAL AGENTS: SMALL PARTICLE AEROSOL; HETEROTYPIC PROTECTION; VIRAL CHEMOTHERAPY; BOVINE REOVIRUS IN MAN.
Am Rev Respir Dis. 1963 Sep;88:SUPPL 135-47. doi: 10.1164/arrd.1963.88.3P2.135.
7
[Acute pericarditis caused by Coxsackie virus B2 with successive polyorganic involvement].
G Mal Infett Parassit. 1970 Oct;22(10):682-6.
8
The aetiology of respiratory tract infections in military personnel. 4. The recovery of Coxsackie A-21 virus from cases with minor respiratory disease.
Acta Pathol Microbiol Scand. 1962;56:465-70.
9
[Viruses and clinical features associated with hospitalized children with acute respiratory infections in Lhasa, Tibet].
Zhonghua Er Ke Za Zhi. 2012 Oct;50(10):740-2.
10
[Acute respiratory diseases caused by Coxsackie virus A 21].
Vojnosanit Pregl. 1970 Apr;27(4):177-9.
引用本文的文献
1
Seasonal Testing, Results, and Effect of the Pandemic on Coxsackievirus Serum Studies.
Microorganisms. 2024 Feb 10;12(2):367. doi: 10.3390/microorganisms12020367.
2
A Monovalent Mt10-CVB3 Vaccine Prevents CVB4-Accelerated Type 1 Diabetes in NOD Mice.
Vaccines (Basel). 2022 Dec 29;11(1):76. doi: 10.3390/vaccines11010076.
3
Phase 1b study of intravenous coxsackievirus A21 (V937) and ipilimumab for patients with metastatic uveal melanoma.
J Cancer Res Clin Oncol. 2023 Aug;149(9):6059-6066. doi: 10.1007/s00432-022-04510-3. Epub 2023 Jan 18.
4
Minimum Infective Dose of the Major Human Respiratory and Enteric Viruses Transmitted Through Food and the Environment.
Food Environ Virol. 2011 Mar;3(1):1-30. doi: 10.1007/s12560-011-9056-7. Epub 2011 Mar 16.
5
Mt10-CVB3 Vaccine Virus Protects against CVB4 Infection by Inducing Cross-Reactive, Antigen-Specific Immune Responses.
Microorganisms. 2021 Nov 10;9(11):2323. doi: 10.3390/microorganisms9112323.
6
Oncolytic virus therapy for cancer.
Oncolytic Virother. 2013 Sep 23;2:31-46. doi: 10.2147/OV.S38901. eCollection 2013.
7
Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.
World J Virol. 2012 Jun 12;1(3):91-107. doi: 10.5501/wjv.v1.i3.91.
8
Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride.
Invest New Drugs. 2012 Apr;30(2):568-81. doi: 10.1007/s10637-010-9614-0. Epub 2010 Dec 21.
9
Discussion.
Bacteriol Rev. 1966 Sep;30(3):584-6. doi: 10.1128/br.30.3.584-586.1966.
10
RESPONSE OF VOLUNTEERS TO INOCULATION WITH HEMAGGLUTININ-POSITIVE AND HEMAGGLUTININ-NEGATIVE VARIANTS OF COXSACKIE A21 VIRUS.
J Clin Invest. 1965 Jul;44(7):1125-31. doi: 10.1172/JCI105219.
本文引用的文献
1
Separation of hemagglutinating and non-hemagglutinating variants of Coxsackie A-21 virus.
Proc Soc Exp Biol Med. 1962 Aug-Sep;110:653-7. doi: 10.3181/00379727-110-27607.
2
A hemagglutination-inhibition technique for typing adenoviruses.
Am J Hyg. 1960 Jan;71:120-8. doi: 10.1093/oxfordjournals.aje.a120085.
3
Inoculation of human volunteers with strains of Coe virus isolated in Britain.
Br Med J. 1960 Jun 11;1(5188):1776-8. doi: 10.1136/bmj.1.5188.1776.
4
Infectivity and interrelationship of 2060 and JH viruses in volunteers.
J Lab Clin Med. 1960 Mar;55:331-41.
5
An outbreak of a summer febrile disease caused by Coxsackie B-2 virus.
Am J Public Health Nations Health. 1960 Sep;50(9):1342-8. doi: 10.2105/ajph.50.9.1342.
6
Virological studies on acute respiratory disease in young adults. I. Isolation of ECHO 28.
Proc Soc Exp Biol Med. 1961 Aug-Sep;107:770-3. doi: 10.3181/00379727-107-26749.
7
Acute respiratory disease associated with Coxsackie A-21 virus infection. II. Incidence in military personnel: observations in a nonrecruit population.
JAMA. 1962 Jan 13;179:120-5. doi: 10.1001/jama.1962.03050020014003.
8
Role of interferon in recovery from virus infections.
Lancet. 1960 Jul 9;2(7141):69-71. doi: 10.1016/s0140-6736(60)91215-0.
9
[Isolation of Coe-virus from patients with acute respiratory disease].
Ned Tijdschr Geneeskd. 1960 Mar 26;104:617-9.
10
Inoculation of human volunteers with parainfluenza viruses types 1 and 3 (HA 2 and HA 1).
Br Med J. 1959 Nov 7;2(5157):909-11. doi: 10.1136/bmj.2.5157.909.
Zotero 插件